Sarepta Therapeutics, Inc. SRPT Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $198.51M.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s total debt?
- Sarepta Therapeutics, Inc. (SRPT) reported total debt of $198.51M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s total debt changed year-over-year?
- Sarepta Therapeutics, Inc.'s total debt decreased by 3.4% year-over-year, from $205.46M to $198.51M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total debt has grown at a 15.8% compound annual growth rate (CAGR), from $101.3M to $210.57M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.